SBIR/STTR Research Award

New Materials for Plague Antigen and Antibody Detection

Award identifier bb05b78f382a6db037290286d26be8ef34279560da5073e237aa0d9b7eadd01fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$98,530

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ANALYTICAL BIOLOGICAL SERVICES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): We propose to develop novel soluble sensing materials that can be used in homogenous fluorescence assays for the detection of Yersinia pestis antigens and antibodies. Y. pestis is the etiological cause of plague and a potential biowarfare agent. The sensing materials are solutions of functionalized liposomes that become fluorescent when they bind selectively to the antibody targets. The solutions will be used to develop both competitive assays for detection of the Y. pestis F1 antigen and direct one-step assays for the detection of Y. pestis antibodies that can be performed in commonly available plate readers. Swift identification of a Y. pestis infection is very important to insure timely and appropriate treatment. Current methods of diagnosis (culture, fluorescent antibody staining, agglutination tests) are slow, complicated, require trained personnel and are not suitable for screening large numbers of samples quickly, in the advent of a biological attack. ELISA and PCR methods for detection of Y. pestis infection are in development, however, these methods also require multiple steps, expensive reagents and/or equipment. The assays developed from our sensing materials will be inexpensive, reliable, simple and swift. The materials will subsequently be adapted for detection of antibody response to other diseases, for medical diagnostics and vaccine research.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.